| 000 | 01072 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250515183619.0 | ||
| 264 | 0 | _c20100408 | |
| 008 | 201004s 0 0 fre d | ||
| 022 | _a0003-4266 | ||
| 024 | 7 |
_a10.1016/j.ando.2009.07.003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChabroux, S | |
| 245 | 0 | 0 |
_a[Diabetes and second-generation (atypical) antipsychotics]. _h[electronic resource] |
| 260 |
_bAnnales d'endocrinologie _cSep 2009 |
||
| 300 |
_a202-10 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntidepressive Agents, Second-Generation _xtherapeutic use |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aDiabetes Complications _xpsychology |
| 650 | 0 | 4 |
_aDiabetes Mellitus _xpsychology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aSchizophrenia _xcomplications |
| 700 | 1 | _aHaffen, E | |
| 700 | 1 | _aPenfornis, A | |
| 773 | 0 |
_tAnnales d'endocrinologie _gvol. 70 _gno. 4 _gp. 202-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ando.2009.07.003 _zAvailable from publisher's website |
| 999 |
_c19102314 _d19102314 |
||